Fischer Medical Ventures Announces FY 2026 Results and Recommends Dividend
Fischer Medical Ventures Limited today announced the outcome of its Board meeting held on May 29, 2026, confirming the audited financial results for the Quarter and Financial Year ended March 31, 2026. The company also recommended a final dividend and approved the appointment of its Internal Auditors for the upcoming financial year.The company, formerly known as Fischer Chemic Limited, reported significant financial figures across its standalone and consolidated statements for the year ended March 31, 2026.Financial Performance Highlights
The financial results provide comprehensive details regarding the company's performance across the year and quarter...